Stand Up to Cancer and the American Association for Cancer Research have announced the launch of a $7.5 million grants program aimed at supporting early-career scientists pursuing innovative research focused on immuno-oncology.
Funded by the Bristol-Myers Squibb Company, the Innovative Research Grants program will award ten three-year grants of up to $750,000 each in support of novel, high-risk, high-reward cancer immunology research projects that have significant potential for translation to clinical application. The deadline for proposals is January 12, 2017.
"Immuno-oncology is an exciting field in research today," said William G. Kaelin, Jr., professor of medicine and associate director of basic science at the Dana-Farber Cancer Institute and Harvard Medical School and chair of the SU2C Innovative Research Grant Committee. "It has yielded a number of revolutionary new approaches to cancer treatment, and we are eager to find and support scientists early in their careers who can help move the field even further forward."